News

Buy Aster DM Healthcare Ltd For Target Rs. 335 - JM Financial Institutional Securities Aster DM’s 1Q Revenue/EBITDA was ahead of JMFe primarily driven by strong GCC performance. Reported PAT was lower than estimates due to one-time tax charge of INR 443mn and new hospital losses of INR 230mn adjusted for which PAT grew 87%YoY. GCC hospital revenues grew 19%YoY with c. 15.6% margin (17% adj. for new hospital losses). The India Hospital revenues (6% beat) was driven by strong ARPOB growth due to price hikes, better case mix and higher cash patients which is expected to sust...
Buy Aster DM Healthcare Ltd For Target Rs. 335 - JM Financial Institutional Securities
Buy Aster DM Healthcare Ltd For Target Rs. 335 - JM Financial Institutional Securities
Source: JM Financial Institutional Securities
21/08/2023 2:24:49 PM
Add Vijaya Diagnostic Centre Ltd Target Rs.530 - Yes Securities Revenue uptick, margin stability key to positive stance Result Synopsis Vijaya reported a better revenue performance with like for like patient volume growth of 13% YoY adjusted for 50k covid patients in the base quarter. Realization per footfall also surprised on the higher side; increase in volumes led to operating leverage which partly offset the rise in other expenses on account of opening of ~5 hubs and 15-20 spokes in the last 12 months. With newly opened centres like Tirupati, Ra...
Add Vijaya Diagnostic Centre Ltd Target Rs.530 - Yes Securities
Add Vijaya Diagnostic Centre Ltd Target Rs.530 - Yes Securities
Source: Yes Securities Ltd
17/08/2023 12:53:04 PM
Indian medical device industry can reach $50 bn by 2030: Mansukh Mandaviya The Indian medical devices industry has the potential to grow at 28 per cent yearly to reach $50 bn by 2030, Union Health Minister Mansukh Mandaviya said on Friday. The industry has the power to emerge as the global leader in manufacturing and innovation in next 25 years, he said while launching the website of India MedTech Expo 2022 (IMTE-22) here. The first ever expo being spearheaded by the government in association with Indian medical devices industry, the three-day IMTE-22 will sta...
Indian medical device industry can reach $50 bn by 2030: Mansukh Mandaviya
Indian medical device industry can reach $50 bn by 2030: Mansukh Mandaviya
Source: IANS
1/10/2022 10:49:01 AM
Buy Shalby Ltd For Target Rs.160 - Ventura Securities All set for growth Shalby Ltd (Shalby), a leading multi-specialty chain of hospitals, completed its major expansion plan to 10 hospitals (1,962 beds from 1,295 beds) in FY17. However, the slow ramp up and the onset of Covid led to low occupancies and consequently, lower return ratios. Despite the challenging times, Shalby was able to sustain a operating revenue CAGR of 16.6% to INR 699 cr over FY17-22 without compromising on margins (which are best in class). With normalcy returning, we...
Buy Shalby Ltd For Target Rs.160 - Ventura Securities
Buy Shalby Ltd For Target Rs.160 - Ventura Securities
Source: Ventura Securities Ltd
15/09/2022 3:47:34 PM
Buy Shalby Ltd For Target Rs.160 - ICICI Direct Growth in surgeries to sustain; implants to ramp up… About the stock: Started by renowned orthopaedic surgeon Dr Vikram Shah, Shalby is a multi-specialty hospitals chain with expertise in joint replacement. * Revenue-wise breakup FY22: anthroplasty:29%, critical care & general medicine: 22%, orthopaedic: 8%, oncology:9%, cardiac science: 8%, neurology 5%, nephrology:3%, others:16% * Shalby registered a blended ARPOB of | 31,347 and ALOS of 4.55 days (without day care proce...
Buy Shalby Ltd For Target Rs.160 - ICICI Direct
Buy Shalby Ltd For Target Rs.160 - ICICI Direct
Source: ICICI Direct
7/06/2022 3:30:32 PM
Buy Vijaya Diagnostic Centre Ltd Target Rs.5250 - Yes Securities Growth thesis intact Result Synopsis Vijaya reported a marginal miss on margin as Covid revenues jumped YoY – about 35- 40 days in the quarter were impacted particularly on radiology along with change in mix in pathology. Expect pickup from March to drive a better QoQ performance exCovid with support from launch of additional centres. Vijaya was impacted by Covid tests for nearly half of 4Q leading to 2% YoY decline in non Covid revenues. This makes comparison difficult on the ...
Buy Vijaya Diagnostic Centre Ltd Target Rs.5250 - Yes Securities
Buy Vijaya Diagnostic Centre Ltd Target Rs.5250 - Yes Securities
Source: Yes Securities Ltd
30/05/2022 11:58:03 AM
Buy Vijaya Diagnostic Centre Ltd For Target Rs.700 - ICICI Securities B2C-focused dominant Southern player Vijaya Diagnostic (Vijaya) is one of the largest integrated diagnostic chains in southern India and is primarily based in Andhra Pradesh and Telangana. Other factors that differentiate Vijaya from other diagnostic chains are: 1) ~92% of business is its B2C (provides stickiness) and 2) it offers a comprehensive basket of diagnostic services in both pathology and radiology. Owing to its B2C focus and higher radiology contribution, Vijaya commands the high...
Buy Vijaya Diagnostic Centre Ltd For Target Rs.700 - ICICI Securities
Buy Vijaya Diagnostic Centre Ltd For Target Rs.700 - ICICI Securities
Source: ICICI Securities
5/01/2022 1:54:27 PM
Buy Shalby Ltd For Target Rs.170 - ICICI Direct Q2 numbers reflect non-Covid momentum… About the stock: Started by renowned orthopaedic surgeon Dr Vikram Shah, Shalby is a multi-specialty hospitals chain with specific expertise in joint replacement. The total bed capacity was at 2112 (FY21). * Therapy-wise breakup Q2FY22: anthroplasty:37%, critical care & general medicine: 13%, orthopaedic: 11%, oncology:8%, cardiac science:8%, neurology 5%, nephrology:3%, others:16% * Shalby registered a blended ARPOB of | 33,977 and A...
Buy Shalby Ltd For Target Rs.170 - ICICI Direct
Buy Shalby Ltd For Target Rs.170 - ICICI Direct
Source: ICICI Direct
3/11/2021 12:34:55 PM
Buy Apollo Hospitals Enterprise Ltd Target Rs. 3950 - Religare Broking Derivative Ideas APOLLOHOSP FUTS added around 4% in open interest as LONG buildup was seen in it. Current chart pattern also indicates further up move in its price. We suggest buying in APOLLOHOSP in cash as per below levels. Strategy:- BUY APOLLOHOSP BETWEEN 3860-3870 STOPLOSS 3825 TARGET 3950.   To Read Complete Report & Disclaimer Click Here   Please refer disclaimer http://ex.religareonline.com/disclaimer SEBI Registration number is INZ000...
Buy Apollo Hospitals Enterprise Ltd Target Rs. 3950 - Religare Broking
Buy Apollo Hospitals Enterprise Ltd Target Rs. 3950 - Religare Broking
Source: Religare Broking Ltd
20/07/2021 11:05:39 AM
Stock Picks - Apollo Hospital Enterprise Ltd and Dabur India Ltd By ICICI Direct Apollo Hospital Buy Apollo Hospital Enterprise Ltd @ 3230.00-3236.00 CMP 3235.40 TGT  3287.00 SL 3203.80   Dabur India  Buy Dabur India Limited @ 537.00-539.00 CMP 539.65 TGT 548.50 SL 532.60   To Read Complete Report & Disclaimer Click Here   https://secure.icicidirect.com/Content/StaticData/Disclaimer.html   Views express by all pa...
Stock Picks - Apollo Hospital Enterprise Ltd and Dabur India Ltd By ICICI Direct
Stock Picks - Apollo Hospital Enterprise Ltd and Dabur India Ltd By ICICI Direct
Source: ICICI Direct
20/05/2021 10:31:41 AM
Stock Picks - Apollo Hospitals Enterprise Ltd and Power Finance Corporation Ltd By ICICI Direct Apollo Hospitals Buy Apollo Hospitals Enterprise Ltd @ 3235.00-3242.00. CMP 3250.95 TGT 3288.00SL 3211.40   Power Finance Corporation Buy Power Finance Corporation Ltd @ 107.50-108.00. CMP 107.80 TGT  106.60 SL 109.00   To Read Complete Report & Disclaimer Click Here   https://secure.icicidirect.com/Content/StaticData/Disclaimer.html   Views expres...
Stock Picks - Apollo Hospitals Enterprise Ltd and Power Finance Corporation Ltd By ICICI Direct
Stock Picks - Apollo Hospitals Enterprise Ltd and Power Finance Corporation Ltd By ICICI Direct
Source: ICICI Direct
30/04/2021 12:17:47 PM
Buy Thyrocare Technologies Limited Target Rs. 1120 - Religare Broking Religare Super Idea       To Read Complete Report & Disclaimer Click Here   Please refer disclaimer http://ex.religareonline.com/disclaimer SEBI Registration number is INZ000174330 Above views are of the author and not of the website kindly read disclaimer
Buy Thyrocare Technologies Limited Target Rs. 1120 - Religare Broking
Buy Thyrocare Technologies Limited Target Rs. 1120 - Religare Broking
Source: Religare Broking Ltd
30/04/2021 10:24:57 AM
Maruti Suzuki to shut Haryana factories to divert oxygen for medical use Maruti Suzuki India has announced the closure of its factories in Haryana to make oxygen available for medical requirements. In a statement, the company said that as part of the car manufacturing process, Maruti Suzuki uses a small amount of oxygen in its factories while relatively much larger quantities are used by the manufacturers of components. "In the current situation, we believe that all available oxygen should be used to save lives. Accordingly, Maruti Suzuki has decided to...
Maruti Suzuki to shut Haryana factories to divert oxygen for medical use
Maruti Suzuki to shut Haryana factories to divert oxygen for medical use
Source: IANS
29/04/2021 9:53:14 AM